Biopanning of single-chain antibodies expressing phages reveals distinct expression patterns of angiogenic and arteriogenic vessels

Endothelium: Journal of Endothelial Cell Research

Volumn 10, Issue 4-5, 2003, Pages 277-284

  Mazur, Anna ^a   Deylig, Andrea ^a   Schaper, Wolfgang ^b   Meinertz, Thomas ^a   Ito, Wulf D ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Angiogenesis; Arteriogenesis; Collateral circulation; Collateral targeting; Phage expression libraries; Single chain antibodies

Indexed keywords

CYCLINE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BACTERIOPHAGE; CLONING; CONTROLLED STUDY; ENDOTHELIUM; HYBRIDOMA; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; SEQUENCE ANALYSIS; TUMOR; VIRUS GENE;

ANIMALIA; PAPILLOMAVIRUS;

EID: 0346098081     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.1080/10623320390246405     Document Type: Article

References (33)

1. Arras M., Ito W.D., Scholz D., Winkler B., Schaper J., and Schaper W. (1998) Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. Journal of Clinical Investigation, 101, 40-50.
2. Arras M., Mollnau H., Strasser R., Wenz R., Ito W.D., Schaper J., and Schaper W. (1998) The delivery of angiogeneic factors to the heart by microsphere therapy. Nature Biotechnology, 16, 158-162.
3. Baroldi G., and Scomazzoni G. (1967) Coronary Circulation in the Normal and the Pathologic Heart. Office of the Surgeon General, Department of the Army, Washington, DC.
4. Dean C.J. (1998) Preparation and testing of monoclonal antibodies to recombinant proteins. In Immunochemical Protocols (ed. J. D. Pound), Humana Press. Totowa, New Jersey, pp. 23-37.
5. De Boer O., Van Der Wal A., Teeling P., and Becker A. (1999) Leucocyte recruitment in rupture prone regions of lipid-rich plaques: A prominent role for neovascularization? Cardiovascular Research, 41, 443-449.
6. Derhaag J.G., Duijvestijn A.M., Emeis J.J., Engels W., and Van Breda Vriesman P.J.C. (1996) Production and characterization of spontaneous rat heart endothelial cell lines. Laboratory Investigations, 74, 437-451.
7. Dor Y., and Keshet E. (2000) Oxygen and tumor angiogenesis. In Angiogenesis in Health and Disease: Basic Mechanisms and Clinical Applications (ed. R. GM), Marcel Dekker, New York, pp. 245-260.
8. Ellerby H., Arap W., Ellerby L., Kain R., Andrusiak R., Del Rio G., Krajewski S., Lombardo C., Rao R., Ruoslahti E., Bredesen D., and Pasqualini R. (1999) Anti-cancer activity of targeted pro-apoptotic peptides. Nature Medicine, 5, 1032-1038.
9. Epstein S., Fuchs S., Zhou Y., Baffour R., and Kornowski R. (2001) Therapeutic interventions for enhancing collateral development by administration of growth factors: Basic principles, early results and potential hazards. Cardiovascular Research, 49, 532-542.
10. Epstein S., Kornowski R., Fuchs S., and Dvorak H. (2001) Angiogenesis therapy - Amidst the hype, the neglected potential for serious side effects. Circulation, 104, 115-119.
11. Freedman S., and Isner J. (2001) Therapeutic angiogenesis for ischemic cardiovascular disease. Journal of Molecular and Cellular Cardiology, 33, 379-393.
12. Fulton W.F.M. (1965) The Coronary Arteries. Charles C Thomas, Springfield, Illinois.
13. Herzog S., Sager H., Khmelevski E., Deylig A., and Ito W. (2002) Collateral arteries grow from preexisting anastomoses in the rat hindlimb. American Journal of Physiology Heart and Circulatory Physiology 283, H2012-H2020.
14. Ito W.D., Arras M., Scholz D., Winkler B., Htun P., and Schaper W. (1997) Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. American Journal of Physiology Heart and Circulatory Physiology, 273, H1255-H1265.
15. Ito W.D., Arras M., Winkler B., Scholz D., Schaper J., and Schaper W. (1997) Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circulation Research, 80, 829-837.
16. Koivunen E., Arap W., Valtanen H., Rainisalo A., Medina O., Heikkila P., Kantor C., Gahmberg C., Salo T., Konttinen Y., Sorsa T., Ruoslahti E., and Pasqualini R. (1999) Tumor targeting with a selective gelatinase inhibitor. Nature Biotechnology, 17, 768-774.
17. Ni Y., Marchal G., Yu J., Lukito G., Petre C., Wevers M., Baert A., Ebert W., Hilger C., Maier F., and Semmler W. (1995) Localization of metalloporphyrin-induced specific enhancement in experimental liver tumors-comparison of magnetic resonance imaging, microangiographic, and histologic findings. Academic Radiology, 2, 687-699.
18. Nicklin S., White S., Watkins S., Hawkins R., and Baker A. (2000) Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display. Circulation, 102, 231-237.
19. Obermeyer N., Janson N., Bergmann J., Buck F., and Ito W.D. (2003) Proteome analysis of migrating versus non-migrating rat heart endothelial cells reveals distinct expression patterns. Endothelium, in press.
20. Rentrop K.P., Feit F., Sherman W., and Thornton J.C. (1989) Serial angiographic assessment of coronary-artery obstruction and collateral flow in acute myocardial-infarction - Report from the 2nd Mount Sinai-New York University Reperfusion in Trial. Circulation, 80, 1166-1175.
21. Risau W. (1997) Mechanisms of angiogenesis. Nature, 386, 671-674.
22. Ruoslahti E., and Rajotte D. (2000) An address system in the vasculature of normal tissues and tumors. Annual Review of Immunology, 18, 813-827.
23. Schaper W., Piek J.J., Munoz-Chapuli R., Wolf C., and Ito W. (1999) Collateral Circulation of the Heart. In Angiogenesis and Cardiovascular Disease (eds. J. A. Ware and M. Simons), Oxford University Press, New York, Oxford, pp. 159-198.
24. Schaper W., and Schaper J. (1993) Collateral Circulation - Heart, Brain, Kidney, Limbs. Boston, Dordrecht, London: Kluwer Academic Publishers.
25. Scholz D., Ito W., Fleming I., Deindl E., Sauer A., Wiesnet M., Busse R., Schaper J., and Schaper W. (2000) Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Archiv - An International Journal of Pathology, 436, 257-270.
26. Simons M. (2000) Phase II, multicenter double-blind, placebo-controlled, dose-finding study for safety, pharmacokinetics, and efficacy of recombinant fibroblast growth factor (rFGF-2) in subjects with coronary artery disease (CAD): FGF-2 initiating revascularization support trial (FIRST). Journal of the American College of Cardiology, 36, 310-311.
27. Simons M., Annex B., Laham R., Kleiman N., Henry T., Dauerman H., Udelson J., Gervino E., Pike M., Whitehouse M., Moon T., and Chronos N. (2002) Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2; Double-blind, randomized, controlled clinical trial. Circulation, 105, 788-793.
28. Simons M., Bonow R.O., Nicolas A.C., Cohen D.J., Giordano F.J., Hammond K., Laham R.J., Li W., Pike M., Sellke F.W., Stegmann T.J., Udelson J.E., and Rosengart T.K. (2000) Clinical trials in coronary angiogenesis: Issues, problems consensus. An expert panel summary. Circulation, 102, e73-e86.
29. Thorpe P., and Ran S. (2000) Tumor infarction by targeting tissue factor to tumor vasculature. Cancer Journal, 6, S237-S244.
30. Watkins S., Mesyanzhinov V., Kurochkina L., and Hawkins R. (1997) The "adenobody" approach to viral targeting: Specific and enhanced adenoviral gene delivery. Gene Therapy, 4, 1004-1012.
31. Wickham T.J., Hakard D., Segal D., and Kovesdi I. (1997) Targeting endothelium for gene therapy via receptors upregulated during angiogenesis and inflammation. Cancer Immunology and Immunotherapy, 45, 149-151.
32. Wickham T.J., Tzeng E., Shears L.L., Roelvink P.W., Li Y., M L.G., Brough D.E., Lizonova A., and Kovesdi I. (1997) Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. Journal of Virology, 71, 8221-8229.
33. Yancopoulos G., Klagsbrun M., and Folkman J. (1998) Vasculogenesis, angiogenesis, and growth factors - Ephrins enter the fray at the border. Cell, 93, 661-664.